Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics in affective disorders.

European journal of pharmacology - 8 Mar 2002

Serretti Alessandro, Lilli Roberta, Smeraldi Enrico

Abstract excerpt

Pharmacogenetics will be of substantial help in the field of affective disorders pharmacotherapy. The possible definition of a genetic liability profile for drug side-effects and efficacy will be of great help in treatments that need weeks to months to be effective. During the last few years, a number of groups have reported possible liability genes. The efficacy and time of onset of selective serotonin reuptake...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Antipsychotic Agents
Share to GTP-Binding Proteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lithium

Share to Mood Disorders

Share to Receptor, Serotonin, 5-HT2A

Share to Receptors, Serotonin

Share to Serotonin Plasma Membrane Transport Proteins

Source

Identifiers

PMID: 11909602
DOI: 10.1016/s0014-2999(02)01309-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics in affective disorders.PMID 11909602Read ↗

Pharmacogenetic considerations in the treatment of psychiatric disorders.Semantic proximity Read ↗

The role of pharmacogenetics in the treatment of depression and anxiety disorders.Semantic proximity Read ↗

Pharmacogenetics in psychiatry--a useful clinical tool or wishful thinking for the future?Semantic proximity Read ↗

Pharmacogenetics in modern psychiatry.Semantic proximity Read ↗

Pharmacogenetics of antidepressive treatment.Semantic proximity Read ↗

Genetics and psychopharmacology: prospects for individualized treatment.Semantic proximity Read ↗

Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directionsSemantic proximity Read ↗

Lithium long-term treatment in mood disorders: clinical and genetic predictors.Semantic proximity Read ↗

Serotonin transporter promoter genotype and illness recurrence in mood disorders.Semantic proximity Read ↗

Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders.Semantic proximity Read ↗

Role of pharmacogenomics in individualising treatment with SSRIs.Semantic proximity Read ↗

Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.